An FT investigation has found a thriving market for stem cell therapies in the US promising longer, healthier lives. Experts say such claims are dangerous
Related stories
How the Iran war unfolded: every attack and oil price change – visualised
Homes for sale with kerb appeal in England and Scotland – in pictures
What do you spend too much on?
I used to live in a quiet area - now a data centre overlooks my garden
Dear culture-war motorists, look to the future. We'll all be driving at 20mph soon | Christian Wolmar
From maligned second city to Insta magnet: Marseille isFrance’s new capital of overtourism